All News #Library
Sciences
An NK cell therapy biotech pulls IPO ambitions weeks after 2nd trial clearance
02 Nov 2022 //
ENDPTS
Dean Li kicks off Merck`s post-Roger Perlmutter era by teaming with Artiva
28 Jan 2021 //
ENDPTS
Dean Li kicks off Merck`s post-Roger Perlmutter era by teaming with Artiva
28 Jan 2021 //
ENDPTS

Market Place
Sourcing Support